Vaccines, blood, antisera, toxins and cultures in Canada | The Observatory of Economic Complexity

About

Exports In 2022, Canada exported $884M in Vaccines, blood, antisera, toxins and cultures, making it the 23rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 106th most exported product in Canada. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Canada are: United States ($519M), Norway ($57M), Belgium ($42.6M), France ($33.4M), and South Korea ($21.5M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Canada between 2021 and 2022 were Dominican Republic ($19.6M), Italy ($10.5M), and United States ($10.1M).

Imports In 2022, Canada imported $7.71B in Vaccines, blood, antisera, toxins and cultures, becoming the 12th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 9th most imported product in Canada. Canada imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($3.24B), Switzerland ($1.47B), Germany ($646M), Belgium ($578M), and Ireland ($547M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Canada between 2021 and 2022 were South Korea ($75.4M), Singapore ($52.3M), and Sweden ($48.3M).

Latest Trends

September 2024

About

Overview In September 2024 Canada's Vaccines, blood, antisera, toxins and cultures exports accounted up to C$87.8M and imports accounted up to C$702M, resulting in a negative trade balance of C$615M. Between September 2023 and September 2024 the exports of Canada's Vaccines, blood, antisera, toxins and cultures have decreased by C$-20.4M (-18.8%) from C$108M to C$87.8M, while imports decreased by C$-239M (-25.4%) from C$941M to C$702M.

Destinations In September 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States (C$52.2M), France (C$7.21M), Netherlands (C$4.99M), Italy (C$3.62M), and South Korea (C$3.33M), and were imported mostly from United States (C$219M), Switzerland (C$112M), Ireland (C$80.8M), Germany (C$78.5M), and Belgium (C$38.6M).

Growth In September 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by a decrease in exports to Mexico (C$-3.19M or -91.1%), Australia (C$-2.25M or -96%), and China (C$-429k or -59.3%). In September 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from United States (C$-371M or -67.6%), Belgium (C$-187M or -73.4%), and South Korea (C$-137M or -89.1%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (September 2023 - September 2024)C$-20.4M(-18.8%)

IMPORT GROWTH (September 2023 - September 2024)C$-239M(-25.4%)

MAIN EXPORTER (September 2024)OntarioC$79.5M

MAIN DESTINATION (September 2024)United StatesC$52.2M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Canada. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download